Analyst firms · H.C. Wainwright · CRTX
H.C. Wainwright CRTX price target and rating history
Cortexyme Inc. (CRTX) · Health Care
H.C. Wainwright rates Cortexyme Inc. (CRTX) Buy with a $15 price target, as of its latest action on Mar 9, 2022. It has published 3 rating actions on CRTX since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $15
- Median target, all firms
- Too few
- Actions on CRTX
- 3
H.C. Wainwright price target on CRTX
Every H.C. Wainwright rating on CRTX
- Mar 9, 2022
- Oct 27, 2021
- Aug 26, 2021
Questions about H.C. Wainwright and CRTX
- What is H.C. Wainwright's price target for CRTX?
- H.C. Wainwright's latest stated price target for Cortexyme Inc. (CRTX) is $15, from its action on Mar 9, 2022.
- What is H.C. Wainwright's rating on CRTX?
- H.C. Wainwright rates CRTX Buy, a bullish rating, as of Mar 9, 2022.
- When did H.C. Wainwright last change its view on CRTX?
- On Mar 9, 2022, H.C. Wainwright cuts its price target to $15 from $30, keeps Buy.
More CRTX rating histories
All H.C. Wainwright ratingsCRTX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.